COMP <GO>
OGN vs MRK // RSI-14 & 200D SMA MOMENTUM
Organon & Co. (NYSE) VS. Merck & Company Inc. (NYSE) • 15-METRIC TALLY: OGN 5
— MRK 5
▲ RSI-14 & 200D SMA MOMENTUM LEADER: OGN
LAST: $13.84 (+0.22%) • MKT CAP: $3.63B
rsi-technicals
60.4
LAST: $149.52 (+2.18%) • MKT CAP: $361.02B
rsi-technicals
51.7
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (OGN VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | OGN | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 53.30% | 74.80% | -21.50 | MRK | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 24.90% | 20.70% | +4.20 | OGN | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 15.3x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 14.83% | 3.42% | +11.41 | OGN | /fcf-yield <GO> |
| Operating Margin | — | 34.30% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | 3.00% | 28.10% | -25.10 | MRK | /net-margins <GO> |
| Revenue Growth (YoY) | -2.90% | 1.30% | -4.20 | MRK | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 2.43% | 2.26% | +0.17 | OGN | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 5.19 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 7/9 | -1.00 | MRK | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 60.4 | 51.7 | +8.70 | OGN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.92 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 18.0x | 18.4x | -0.40 | OGN | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $3.63B | $361.02B | -$357.39B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | OGN REV | MRK REV | OGN GROSS % | MRK GROSS % | OGN FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $6.22B | $65.01B | 53.3% | 74.8% | $538.0M | $12.36B |
| FY 2024 | $6.40B | $64.17B | 58.0% | 76.3% | $764.0M | $18.10B |
| FY 2023 | $6.26B | $60.12B | — | — | $799.0M | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
OGN // BETA —
MRK // BETA 0.92